DASH Pharmaceuticals is a high quality, specialty generics company which is now part of Natco Pharma, Ltd. Our finished dosages formulation business is primarily focused on high-entry-barrier products that are difficult to formulate and/or manufacture. In addition, DASH has and is developing a growing portfolio of unit dose products for institutional use.